ArticleBMC medicine2017

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.

Renée T Fortner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.